04:31

Tools for optimising treatment & management of advanced NETs

05:31

The evolving role of liquid biopsy

03:09

Highlights: Precision oncology in practice- testing through to treatment in lung and prostate cancer

08:57

Advanced renal cell carcinoma: Managing long term durable response

05:13

Advanced HCC: Treatment options for patients ineligible for IO - patient case video

05:26

Highlights- Optimising the management of multiple myeloma in the early relapsed refractory setting

01:16:23

Optimising the management of multiple myeloma in the early relapsed/refractory setting

08:19

GI CONNECT Update from ASCO 2024

03:14

Lung Cancer – Meeting Highlights from ASCO 2024

11:57

Update from ASCO 2024

21:48

Regional differences in NET: Epidemiology, diagnosis, and referral strategies: Part 1

21:17

Regional differences in NET (neuroendocrine tumours): Treatment and future developments - Part 2

01:20:28

Precision oncology in practice – testing through to treatment in lung and prostate cancer

01:41:37

2nd China-Europe Anti-Cancer Summit 2024 - Webinar replay

05:41

Chronic hypophosphatemia: Differential diagnosis in children and adults

25:27

Understanding the needs of different patient populations in colorectal cancer

29:55

Câncer de próstata: Desafios da fase pré-analítica e teste de biomarcadores

27:38

Thrombophilia Screening: Best Practices and Who Should be Tested?

27:55

Interpreting real-world evidence in later-line mCRC

32:23

Câncer de ovário: Desafios da fase pré-analítica e teste de biomarcadores

27:49

Cáncer de pulmón: dificultades en la fase preanalítica y pruebas de biomarcadores

27:49

Câncer de pulmão: Desafios da fase pré-analítica e teste de biomarcadores

29:55

Cáncer de próstata: dificultades en la fase preanalítica y pruebas de biomarcadores

32:23

Cáncer de ovario: dificultades en la fase preanalítica y pruebas de biomarcadores

23:33

Severe postpartum hemorrhage (PPH) - Learnings from clinical practice: Episode 2

01:23

The Escape Game

11:05

Panel Discussion and Summary: Current and Future Gastroesophageal Cancer Treatments

37:02

Normalising haemostasis in Haemophilia – A new standard of care

05:06

PARP inhibitor monotherapy

15:12

Panel discussion and summary Treatment Options for HCC Patients

02:21

10 years of independent medical education in GI oncology

11:22

Treating ER+/HER2-low metastatic breast cancer, 2L and beyond

06:08

ER+ advanced breast cancer: Highlights from EBCC-14 satellite symposium

23:41

mCRC: Optimising patient outcomes with late-line treatment

04:27

Advanced HCC: When to switch to 2nd line treatment - a patient case video

25:45

What is severe postpartum hemorrhage (PPH)? Definition, diagnosis & real-world incidence: Episode 1

05:30

ER+ metastatic breast cancer: Elacestrant and beyond

02:02:16

Sino-Europe Anti-Cancer Summit

23:25

Perseverance in molecular testing pays off – Looking beyond the obvious mutations in NSCLC

22:38

Episode 2: Cardiology and Neurology Clinical Case, Dialogue Between the Heart and the Brain

29:37

Episode 1: Cardiology and Neurology Clinical Case, Dialogue Between the Heart and the Brain

19:35

Episode 3: Panel Discussion, Dialogue Between the Heart and the Brain

19:52

Episode 4: Panel Discussion and Summary, New Oral Endocrine Therapy Options for Patients

03:57

M1 - PARP inhibitors as monotherapy in advanced prostate cancer

04:02

M2 - Evolving landscape of PARP inhibitors in mCRPC: combination with anti-androgens

04:11

How to manage pain during intrauterine device (IUD) placement

01:14:05

Best Approaches to Treat MI Patients

01:23:42

EKS Prevention and Management of Heart Disease in T2D Patients

06:17

El papel de Enfermería en el manejo del paciente con CPRCnm

00:57

Tanya Overview of efficacy and safety data of combination therapy with PARPi and NHAs.mp4

01:13

Neeraj Overview of efficacy and safety data of combination therapy with PARPi and NHAs.mp4

24:11

What are the new developments in the treatment of severe postpartum hemorrhage? Episode 4

32:22

Ovarian cancer: Pre-analytical phase challenges and biomarker testing

09:44

Navigating ER+ metastatic breast cancer: Explore a patient case

05:54

Oral SERDS: New endocrine therapy options in ER+ metastatic breast cancer - a patient case video

27:25

Thrombophilia: Clinical overview and impact on patients

05:46

Precision Oncology Update from ASCO and WCGIC 2023

27:49

Lung cancer: Pre-analytical phase challenges and biomarker testing

27:40

Gene therapy and gene-modified cell therapies: current role, potential and the example of hemophilia

35:31

How can you reduce pain and anxiety in IUD placement? Listen to find out more!